Background: Antibody persistence is evaluated in healthy Australian children 4 and 5 years postvaccination with a single dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine (Hib-MenC-TT) compared with separately administered Hib-TT and MenC-CRM197 vaccines (Hib + MCC). Methods: This is another follow-up of a phase III, open, randomized, controlled study (NCT00326118), in which 433 Hib-primed but MenC naïve toddlers aged 12-18 months were randomized 3:1 to receive Hib-MenC-TT or Hib + MCC vaccines. Protection against (1) MenC was measured by serum bactericidal antibody assay using rabbit complement (rSBA) and (2) Hib was measured by enzyme-linked immunosorbent assay of antibodies...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or sep...
BACKGROUND: Persistence of seroprotective bactericidal antibody titers is important for long-term pr...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND:We assessed immunogenicity, antibody persistence and safety of the meningococcal serogrou...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
BACKGROUND: The multicomponent serogroup B meningococcal (4CMenB) vaccine induces antibodies against...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are ad...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodi...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or sep...
BACKGROUND: Persistence of seroprotective bactericidal antibody titers is important for long-term pr...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND:We assessed immunogenicity, antibody persistence and safety of the meningococcal serogrou...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
BACKGROUND: The multicomponent serogroup B meningococcal (4CMenB) vaccine induces antibodies against...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are ad...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodi...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or sep...